|
|
HAART对HIV/AIDS患者实验室指标影响的研究进展
|
Abstract:
高效抗逆转录病毒治疗(HAART)是目前治疗HIV/AIDS最为有效的方法。通过多种抗逆转录病毒药物的联合应用，HAART能够有效抑制病毒复制，从而显著改善患者的预后。然而，长期接受HAART治疗可能会对患者的多项实验室指标产生影响，包括血常规、肝功能、肾功能、血脂和血糖等。这些影响与药物种类、治疗方案、患者个体差异以及合并症等多种因素密切相关。本文还探讨了HAART不良反应的监测与应对策略，并展望了未来的研究方向。通过深入探索这些研究方向，有望进一步优化HAART治疗方案，提高HIV/AIDS患者的治疗效果和生活质量。
High efficiency antiretroviral therapy (HAART) is currently the most effective method for treating HIV/AIDS. Through the combination of multiple antiretroviral drugs, HAART can effectively inhibit virus replication, thereby significantly improving the prognosis of patients. However, long-term treatment with HAART may have an impact on multiple laboratory indicators of patients, including blood routine, liver function, kidney function, blood lipids, and blood glucose. These effects are closely related to various factors such as drug types, treatment plans, individual patient differences, and comorbidities. This article also explores the monitoring and response strategies for adverse reactions of HAART, and looks forward to future research directions. By exploring these research directions in depth, it is expected to further optimize the HAART treatment plan and improve the treatment efficacy and quality of life of HIV/AIDS patients.
| [1] | 中国艾滋病诊疗指南(2021年版) [J]. 中国艾滋病性病, 2021, 27(11): 1182-1201. |
| [2] | 李萌萌, 张景慧. 艾滋病流行现状研究进展[J]. 临床医学进展, 2023, 13(2): 1601-1606. |
| [3] | 何纳. 中国艾滋病流行病学研究新进展[J]. 中华疾病控制杂志, 2021, 25(12): 1365-1368+1480. |
| [4] | Rodger, A.J., et al. (2013) Risk of HIV Transmission through Condomless Sex in Serodifferent Gay Couples with the HIV-Positive Partner Taking Suppressive Antiretroviral Therapy (PARTNER): Final Results of a Multicentre, Prospective, Observational Study. The Lancet, 393, 2428-2438. |
| [5] | Cohen, M.S., Chen, Y.Q. and Mccauley, M. (2011) Antiretroviral Therapy for the Prevention of HIV-1 Transmission. The New England Journal of Medicine, 375, 830-839. |
| [6] | Bavinton, B.R., Pinto, A.N., Phanuphak, N., Grinsztejn, B., Prestage, G.P., Zablotska-Manos, I.B., et al. (2018) Viral Suppression and HIV Transmission in Serodiscordant Male Couples: An International, Prospective, Observational, Cohort Study. The Lancet HIV, 5, e438-e447. https://doi.org/10.1016/s2352-3018(18)30132-2 |
| [7] | 陈超余, 吴南屏. 长期高效抗逆转录病毒治疗对HIV/AIDS患者预期寿命的影响[J]. 国际流行病学传染病学杂志, 2019, 46(5): 398-400. |
| [8] | Ademuyiwa, S.E.A., Saliu, I.O., Akinola, B.K., Akinmoladun, A.C., Olaleye, M.T., Ademuyiwa, A.I., et al. (2022) Impact of Highly Active Antiretroviral Drug Therapy (HAART) on Biochemical, Hematologic, Atherogenic and Anthropometric Profiles of Human Immunodeficiency Virus Patients at a Tertiary Hospital in Owo, Nigeria. Bulletin of the National Research Centre, 46, 1-9. https://doi.org/10.1186/s42269-022-00953-3 |
| [9] | Eggleton, J.S. and Nagalli, S. (2024) Highly Active Antiretroviral Therapy (HAART). StatPearls Publishing. |
| [10] | Yan, H.Y., He, W.M., Li, G.X., et al. (2023) Analysis of the Occurrence Time and Risk Factors of Anemia in Aids Patients Caused by HAART Regimen Containing Zidovudine. Journal of China Pharmacy, 34, 2620-2624. |
| [11] | 颜海燕, 何文明, 李国贤, 等. 含齐多夫定的HAART方案致艾滋病患者贫血的发生时间及危险因素分析[J]. 中国药房, 2023, 34(21): 2620-2624. |
| [12] | Ogweno, G. (2023) Challenges in Platelet Functions in HIV/AIDS Management. In: Infectious Diseases, IntechOpen, p. 8. https://doi.org/10.5772/intechopen.105731 |
| [13] | Darge, T., Babusha, A., Chilo, D., Dukessa, A. and Teferi, S. (2024) Predictors of Severe Hepatotoxicity among Retroviral Infected Adults on HAART Regimen in Ilubabor Zone, Southwest Ethiopia. Scientific Reports, 14, Article No. 8473. https://doi.org/10.1038/s41598-024-57900-7 |
| [14] | Benedicto, A.M., Fuster-Martínez, I., Tosca, J., Esplugues, J.V., Blas-García, A. and Apostolova, N. (2021) NNRTI and Liver Damage: Evidence of Their Association and the Mechanisms Involved. Cells, 10, Article No. 1687. https://doi.org/10.3390/cells10071687 |
| [15] | Strauss, K.E., Phoswa, W.N. and Mokgalaboni, K. (2024) The Impact of Antiretroviral Therapy on Liver Function among Pregnant Women Living with HIV in Co-Existence with and without Pre-Eclampsia. Viruses, 17, Article No. 28. https://doi.org/10.3390/v17010028 |
| [16] | 陈微, 杨秋艺, 曾小良. 艾滋病免疫重建不良影响因素研究进展[J]. 中国公共卫生, 2024, 40(12): 1526-1531. |
| [17] | 欧汝志, 李雪琴, 秦英梅, 等. 替诺福韦减量服用对艾滋病合并慢性肾脏病患者的临床效果分析[J]. 新发传染病电子杂志, 2023, 8(3): 25-28. |
| [18] | 胡峰, 彭武建, 李桂霞, 等. 联合抗病毒治疗药物对艾滋病患者肾损伤的临床观察[J]. 世界最新医学信息文摘(连续型电子期刊), 2020, 20(3): 55-56. |
| [19] | Mchwampaka, J.P., Amadi, M. and Mbare, N.S. (2025) Modeling the Impact of Antiretroviral Therapy on HIV and Related Kidney Diseases in Tanzania. Scientific Reports, 15, Article No. 9094. https://doi.org/10.1038/s41598-025-94114-x |
| [20] | Jafari, A., Khalili, H. and Dashti-Khavidaki, S. (2014) Tenofovir-Induced Nephrotoxicity: Incidence, Mechanism, Risk Factors, Prognosis and Proposed Agents for Prevention. European Journal of Clinical Pharmacology, 70, 1029-1040. https://doi.org/10.1007/s00228-014-1712-z |
| [21] | 乐晓琴, 张仁芳. 富马酸替诺福韦二吡呋酯对艾滋病患者肾脏毒性的研究进展[J]. 新发传染病电子杂志, 2018, 3(3): 150-152. |
| [22] | 赵洋乐, 刘庆军. HIV感染人群肾结石流行病学及治疗的研究进展[J]. 临床泌尿外科杂志, 2022, 37(5): 401-405. |
| [23] | 张海云, 张润松, 肖招英, 等. 嵊州市HIV/AIDS病例HAART治疗依从性的影响因素研究[J]. 预防医学, 2021, 33(3): 277-279+283. |
| [24] | 陈素庭, 许国章. HIV感染及抗病毒治疗与糖尿病关系研究进展[J]. 中华流行病学杂志, 2022, 43(4): 598-602. |
| [25] | 陆静毅, 戴冬君, 周健. 糖尿病管理新指标: 葡萄糖在目标范围内时间的研究现状及展望[J]. 中华医学杂志, 2020, 100(38): 2961-2965. |
| [26] | Woerle, H.J., Mariuz, P.R., Meyer, C., Reichman, R.C., Popa, E.M., Dostou, J.M., et al. (2003) Mechanisms for the Deterioration in Glucose Tolerance Associated with HIV Protease Inhibitor Regimens. Diabetes, 52, 918-925. https://doi.org/10.2337/diabetes.52.4.918 |
| [27] | Koster, J.C., Remedi, M.S., Qiu, H., Nichols, C.G. and Hruz, P.W. (2003) HIV Protease Inhibitors Acutely Impair Glucose-Stimulated Insulin Release. Diabetes, 52, 1695-1700. https://doi.org/10.2337/diabetes.52.7.1695 |
| [28] | Hertel, J., Struthers, H., Horj, C.B. and Hruz, P.W. (2004) A Structural Basis for the Acute Effects of HIV Protease Inhibitors on GLUT4 Intrinsic Activity. Journal of Biological Chemistry, 279, 55147-55152. https://doi.org/10.1074/jbc.m410826200 |
| [29] | Brown, T.T., Li, X., Cole, S.R., Kingsley, L.A., Palella, F.J., Riddler, S.A., et al. (2005) Cumulative Exposure to Nucleoside Analogue Reverse Transcriptase Inhibitors Is Associated with Insulin Resistance Markers in the Multicenter AIDS Cohort Study. AIDS, 19, 1375-1383. https://doi.org/10.1097/01.aids.0000181011.62385.91 |
| [30] | Karamchand, S., Leisegang, R., Schomaker, M., Maartens, G., Walters, L., Hislop, M., et al. (2016) Risk Factors for Incident Diabetes in a Cohort Taking First-Line Nonnucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy. Medicine, 95, e2844. https://doi.org/10.1097/md.0000000000002844 |
| [31] | Willig, A.L. and Overton, E.T. (2016) Metabolic Complications and Glucose Metabolism in HIV Infection: A Review of the Evidence. Current HIV/AIDS Reports, 13, 289-296. https://doi.org/10.1007/s11904-016-0330-z |
| [32] | Cunha, J., Maselli, L., et al. (2015) The Impact of Modern Antiretroviral Therapy on Lipid Metabolism of HIV-1 Infected Patients. |
| [33] | 李智慧, 沙敏, 吴健强. 艾滋病患者糖脂代谢的研究现状[J]. 临床医学进展, 2022, 12(8): 7307-7313. |
| [34] | 严冬梅, 王宗正, 蔡琳, 等. TLE方案对初治男男性行为者的HIV/AIDS患者血脂及致动脉粥样硬化率的影响[J]. 中国艾滋病性病, 2021, 27(1): 21-24. |
| [35] | 刘亚楠, 马彦民, 陈莉华, 等. 河南某地女性HIV/AIDS患者高脂血症及影响因素分析[J]. 中国皮肤性病学杂志, 2021, 35(6): 646-650+669. |
| [36] | Acquired Immunodeficiency Syndrome Professional Group, Society of Infectious Diseases, Chinese Medical Association; Chinese Center for Disease Control, 等. 中国艾滋病诊疗指南(2024版) [J]. 新发传染病电子杂志, 2024, 9(4): 68-94. |
